DR. RAJESH PONUGUPATI. EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 23, n. 2, p. 237–246, 2016. DOI: 10.53555/am143177. Disponível em: https://jptcp.com/index.php/jptcp/article/view/13050. Acesso em: 17 sep. 2026.